These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7847221)

  • 1. MR of intracranial tumors: combined use of gadolinium and magnetization transfer.
    Kurki T; Niemi P; Valtonen S
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1727-36. PubMed ID: 7847221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-enhanced magnetization transfer contrast imaging of intracranial tumors.
    Kurki TJ; Niemi PT; Lundbom N
    J Magn Reson Imaging; 1992; 2(4):401-6. PubMed ID: 1633392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect.
    Petrella JR; Grossman RI; McGowan JC; Campbell G; Cohen JA
    AJNR Am J Neuroradiol; 1996; 17(6):1041-9. PubMed ID: 8791914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
    Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of half-dose gadolinium-enhanced MRI and magnetization transfer saturation in brain tumors.
    Haba D; Pasco Papon A; Tanguy JY; Burtin P; Aube C; Caron-Poitreau C
    Eur Radiol; 2001; 11(1):117-22. PubMed ID: 11194902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spin-lattice relaxation and magnetization transfer in intracranial tumors in vivo: effects of Gd-DTPA on relaxation parameters.
    Kurki T; Komu M
    Magn Reson Imaging; 1995; 13(3):379-85. PubMed ID: 7791547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetization transfer or spin-lock? An investigation of off-resonance saturation pulse imaging with varying frequency offsets.
    Ulmer JL; Mathews VP; Hamilton CA; Elster AD; Moran PR
    AJNR Am J Neuroradiol; 1996 May; 17(5):805-19. PubMed ID: 8733952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
    Wessbecher FW; Maravilla KR; Dalley RW
    AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
    Meyers SP; Wildenhain S; Chess MA; Tarr RW
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems with the "dural tail" sign.
    Gupta S; Gupta RK; Banerjee D; Gujral RB
    Neuroradiology; 1993; 35(7):541-2. PubMed ID: 8232886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evaluation of fluid-attenuated inversion-recovery MR in the diagnosis of intracranial tumors.
    Tsuchiya K; Mizutani Y; Hachiya J
    AJNR Am J Neuroradiol; 1996; 17(6):1081-6. PubMed ID: 8791919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer.
    Finelli DA; Hurst GC; Gullapali RP; Bellon EM
    Radiology; 1994 Feb; 190(2):553-9. PubMed ID: 8284415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dose and field strength on enhancement with paramagnetic contrast media.
    Lindsey RO; Yetkin FZ; Prost R; Haughton VM
    AJNR Am J Neuroradiol; 1994 Nov; 15(10):1849-52. PubMed ID: 7863934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lesion enhancement on spin-echo and gradient-echo images.
    Chappell PM; Pelc NJ; Foo TK; Glover GH; Haros SP; Enzmann DR
    AJNR Am J Neuroradiol; 1994 Jan; 15(1):37-44. PubMed ID: 8141064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrast-enhanced MR "magnetization transfer technique". Improved tumor contrast, delineation and visibility of intracranial malignant gliomas and metastases in radiosurgical treatment planning].
    Hawighorst H; Schreiber W; Debus J; Knopp MV; Engenhart-Cabillic R; Brix G; Essig M; van Kaick G
    Strahlenther Onkol; 1997 Dec; 173(12):684-92. PubMed ID: 9454354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 17. [Magnetization transfer contrast imaging of brain tumors].
    Lundbom N; Kurki T; Komu M; Kormano M
    Rontgenpraxis; 1995 Feb; 48(2):42-4. PubMed ID: 7709289
    [No Abstract]   [Full Text] [Related]  

  • 18. The utility of contrast media in MRI at 0.02 T. A preliminary report.
    Kormano M; Niemi P; Paajanen H; Määttänen H; Katevuo K
    Invest Radiol; 1988 Sep; 23 Suppl 1():S289-91. PubMed ID: 3198364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroscopic tumor volume of malignant glioma determined by contrast-enhanced magnetic resonance imaging with and without magnetization transfer contrast.
    Hawighorst H; Schreiber W; Knopp MV; Essig M; Engenhart-Cabilic R; Brix G; van Kaick G
    Magn Reson Imaging; 1996; 14(10):1119-26. PubMed ID: 9065901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.